X icon

CD20$2,139.61 BTC$77,131.14 ETH$2,384.60 XRP$1.35 SOL$99.43

Loading chart...

CD20$2,139.61 BTC$77,131.14 ETH$2,384.60 XRP$1.35 SOL$99.43

ABBVABBV

$259.52

As of today at 12:55 PM ET

Key Stats

Market Cap$453.124B

Volume (24h)1,782,257

Day's Range$257.73-$262.84

52-Week Range$190.75-$267.47

PE Ratio127.22

EPS2.04

Net Income (FY)$4.23B

Revenue (FY)$61.16B

About ABBVIE INC.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Website: abbvie.com
Industry: PHARMACEUTICAL PREPARATIONS
Full-time Employees: 57,000
Headquarters: NORTH CHICAGO
IPO Date: Dec 10, 2012